- Correlations between the cardiovascular effects of pimobendan and plasma concentrations of the parent compound and of its major active metabolite, UD-CG 212 CL, in patients with congestive heart failure. Hagemeijer, F., Roth, W., Brand, H.J. J. Cardiovasc. Pharmacol. (1989)